| 000 | 01174 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516040156.0 | ||
| 264 | 0 | _c20110906 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1744-7674 | ||
| 024 | 7 |
_a10.1517/13543776.2011.574614 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheung, Chun Hei Antonio | |
| 245 | 0 | 0 |
_aAurora kinase inhibitor patents and agents in clinical testing: an update (2009-10). _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic patents _cJun 2011 |
||
| 300 |
_a857-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAurora Kinases |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatents as Topic |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aCoumar, Mohane Selvaraj | |
| 700 | 1 | _aChang, Jang-Yang | |
| 700 | 1 | _aHsieh, Hsing-Pang | |
| 773 | 0 |
_tExpert opinion on therapeutic patents _gvol. 21 _gno. 6 _gp. 857-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543776.2011.574614 _zAvailable from publisher's website |
| 999 |
_c20854006 _d20854006 |
||